Variant report

Variant	esv3377837
Chromosome Location	chr19:39727555-39735103
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr19:39728457-39728802	HepG2	liver:	n/a	chr19:39728593-39728609 chr19:39728579-39728595
2	BHLHE40	chr19:39728423-39728840	GM12878	blood:	n/a	chr19:39728593-39728609 chr19:39728579-39728595
3	BHLHE40	chr19:39728458-39728820	K562	blood:	n/a	chr19:39728593-39728609 chr19:39728579-39728595
4	CEBPB	chr19:39731115-39731428	IMR90	lung:	n/a	chr19:39731251-39731262
5	CEBPB	chr19:39731134-39731355	A549	lung:	n/a	chr19:39731251-39731262
6	CEBPB	chr19:39729120-39729238	HepG2	liver:	n/a	chr19:39729176-39729187
7	CEBPB	chr19:39731083-39731405	A549	lung:	n/a	chr19:39731251-39731262
8	CEBPB	chr19:39731083-39731426	HepG2	liver:	n/a	chr19:39731251-39731262
9	CEBPB	chr19:39731092-39731382	K562	blood:	n/a	chr19:39731251-39731262
10	CEBPB	chr19:39731146-39731288	Hela-S3	cervix:	n/a	chr19:39731251-39731262
11	CEBPB	chr19:39731155-39731303	HepG2	liver:	n/a	chr19:39731251-39731262
12	CEBPB	chr19:39731085-39731436	K562	blood:	n/a	chr19:39731251-39731262
13	CEBPB	chr19:39731088-39731408	A549	lung:	n/a	chr19:39731251-39731262
14	CEBPB	chr19:39731139-39731423	H1-hESC	embryonic stem cell:	n/a	chr19:39731251-39731262
15	CHD2	chr19:39728561-39728708	Hela-S3	cervix:	n/a	n/a
16	CTCF	chr19:39728640-39728790	GM12878	blood:	n/a	n/a
17	CTCF	chr19:39728600-39728750	GM12868	blood:	n/a	n/a
18	CTCF	chr19:39728520-39728670	Caco-2	colon:	n/a	n/a
19	E2F6	chr19:39728444-39728755	K562	blood:	n/a	chr19:39728580-39728590
20	EBF1	chr19:39728362-39728809	GM12878	blood:	n/a	chr19:39728601-39728612 chr19:39728602-39728612
21	EBF1	chr19:39728418-39728780	GM12878	blood:	n/a	chr19:39728601-39728612 chr19:39728602-39728612
22	EBF1	chr19:39728436-39728777	GM12878	blood:	n/a	chr19:39728601-39728612 chr19:39728602-39728612
23	EGR1	chr19:39728484-39728952	MCF-7	breast:	n/a	chr19:39728749-39728764 chr19:39728575-39728585 chr19:39728750-39728763 chr19:39728750-39728763 chr19:39728541-39728554
24	EGR1	chr19:39728603-39728843	K562	blood:	n/a	chr19:39728749-39728764 chr19:39728750-39728763 chr19:39728750-39728763
25	EGR1	chr19:39728556-39728878	K562	blood:	n/a	chr19:39728749-39728764 chr19:39728575-39728585 chr19:39728750-39728763 chr19:39728750-39728763
26	ELF1	chr19:39728285-39728942	MCF-7	breast:	n/a	n/a
27	ELF1	chr19:39728408-39728883	MCF-7	breast:	n/a	n/a
28	ELF1	chr19:39728556-39728800	K562	blood:	n/a	n/a
29	ELF1	chr19:39728081-39728806	K562	blood:	n/a	n/a
30	ELF1	chr19:39728527-39728813	HepG2	liver:	n/a	n/a
31	ELF1	chr19:39728408-39728855	GM12878	blood:	n/a	n/a
32	HDAC2	chr19:39728336-39728846	MCF-7	breast:	n/a	n/a
33	HDAC2	chr19:39728307-39728829	MCF-7	breast:	n/a	n/a
34	HMGN3	chr19:39728665-39728669	K562	blood:	n/a	n/a
35	IRF1	chr19:39728474-39728768	K562	blood:	n/a	chr19:39728609-39728626 chr19:39728608-39728622 chr19:39728610-39728624 chr19:39728606-39728620 chr19:39728610-39728620 chr19:39728611-39728622 chr19:39728575-39728589
36	MAX	chr19:39728482-39728772	K562	blood:	n/a	chr19:39728753-39728763
37	MAX	chr19:39728553-39728748	HepG2	liver:	n/a	n/a
38	MAX	chr19:39728304-39728948	MCF-7	breast:	n/a	chr19:39728753-39728763 chr19:39728844-39728854 chr19:39728797-39728807
39	MAX	chr19:39728415-39728824	H1-hESC	embryonic stem cell:	n/a	chr19:39728753-39728763 chr19:39728797-39728807
40	MAX	chr19:39728495-39728703	GM12878	blood:	n/a	n/a
41	MAX	chr19:39728379-39728755	MCF-7	breast:	n/a	n/a
42	MAX	chr19:39728392-39728824	ECC-1	luminal epithelium:	n/a	chr19:39728753-39728763 chr19:39728797-39728807
43	MAX	chr19:39728412-39728820	NB4	blood:	n/a	chr19:39728753-39728763 chr19:39728797-39728807
44	MAX	chr19:39728488-39728733	K562	blood:	n/a	n/a
45	MAX	chr19:39728290-39729037	HCT-116	colon:	n/a	chr19:39728753-39728763 chr19:39728844-39728854 chr19:39728797-39728807
46	MAX	chr19:39728452-39728776	Hela-S3	cervix:	n/a	chr19:39728753-39728763
47	MAX	chr19:39728142-39728859	K562	blood:	n/a	chr19:39728753-39728763 chr19:39728844-39728854 chr19:39728797-39728807
48	MAX	chr19:39728348-39728877	HCT-116	colon:	n/a	chr19:39728753-39728763 chr19:39728844-39728854 chr19:39728797-39728807
49	MAX	chr19:39728362-39728899	ECC-1	luminal epithelium:	n/a	chr19:39728753-39728763 chr19:39728844-39728854 chr19:39728797-39728807
50	MAX	chr19:39728363-39728853	HepG2	liver:	n/a	chr19:39728753-39728763 chr19:39728797-39728807

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:39734312-39734362	MCF10A-Er-Src	breast:	n/a
2	chr19:39734312-39734362	GM12878	blood:	n/a
3	chr19:39734312-39734362	HL-60	blood:	n/a
4	chr19:39734312-39734362	Hela-S3	cervix:	n/a
5	chr19:39734312-39734362	Caco-2	colon:	n/a
6	chr19:39734312-39734362	ProgFib	skin:	n/a
7	chr19:39734312-39734362	BJ	skin:	n/a
8	chr19:39734312-39734362	H1-hESC	embryonic stem cell:	embryo
9	chr19:39734312-39734362	IMR90	lung:	fetal
10	chr19:39734312-39734362	SK-N-SH	brain:	n/a
11	chr19:39734312-39734362	HRCEpiC	kidney:	n/a
12	chr19:39734312-39734362	ECC-1	luminal epithelium:	n/a
13	chr19:39734312-39734362	HRPEpiC	eye:	n/a
14	chr19:39734312-39734362	NHDF-neo	bronchial:	n/a
15	chr19:39734312-39734362	K562	blood:	n/a
16	chr19:39734312-39734362	SK-N-SH_RA	brain:	n/a
17	chr19:39734312-39734362	BE2_C	brain:	n/a
18	chr19:39734312-39734362	HEEpiC	esophagus:	n/a
19	chr19:39734312-39734362	HCM	heart:	n/a
20	chr19:39734312-39734362	AG10803	skin:	n/a
21	chr19:39734312-39734362	HEK293	kidney:	embryo
22	chr19:39734312-39734362	HMEC	breast:	n/a
23	chr19:39734312-39734362	GM06990	blood:	n/a
24	chr19:39734312-39734362	HNPCEpiC	eye:	n/a
25	chr19:39734312-39734362	Hepatocyte	liver:	n/a
26	chr19:39734312-39734362	HAEpiC	amniotic membrane:	n/a
27	chr19:39734312-39734362	LNCaP	prostate:	n/a
28	chr19:39734312-39734362	CMK	blood:	n/a
29	chr19:39734312-39734362	U87	brain:	n/a
30	chr19:39734312-39734362	AG04450	lung:	fetal
31	chr19:39734312-39734362	HCPEpiC	choroid plexus:	n/a
32	chr19:39734312-39734362	NT2-D1	testis:	n/a
33	chr19:39734312-39734362	GM12891	blood:	n/a
34	chr19:39734312-39734362	MCF-7	breast:	n/a
35	chr19:39734312-39734362	A549	lung:	n/a
36	chr19:39734312-39734362	GM12892	blood:	n/a
37	chr19:39734312-39734362	AG09309	skin:	n/a
38	chr19:39734312-39734362	Jurkat	blood:	n/a
39	chr19:39734312-39734362	T-47D	breast:	n/a
40	chr19:39734312-39734362	NB4	blood:	n/a
41	chr19:39734312-39734362	SAEC	small airway:	n/a
42	chr19:39734312-39734362	AG09319	gingival:	n/a
43	chr19:39734312-39734362	AoSMC	blood vessel:	n/a
44	chr19:39734312-39734362	HCF	heart:	n/a
45	chr19:39734312-39734362	RPTEC	kidney:	n/a
46	chr19:39734312-39734362	PANC-1	pancreas:	n/a
47	chr19:39734312-39734362	NH-A	brain:	n/a
48	chr19:39734312-39734362	ovcar-3	ovarian:	n/a
49	chr19:39734312-39734362	HepG2	liver:	n/a
50	chr19:39734312-39734362	HUVEC	blood vessel:	n/a

No.	Distal block	Cell Line	Cell type
1	chr19:39727742..39730631-chr19:39743095..39745930,2	K562	blood:
2	chr19:39727142..39728696-chr19:39832975..39834941,2	K562	blood:
3	chr19:39672896..39675810-chr19:39732374..39734924,2	K562	blood:
4	chr19:39730623..39732344-chr19:39738357..39741028,2	K562	blood:

Variant related genes	Relation type
IFNL3P1	TF binding region
IFNL3P1	CpG island
ENSG00000179134	chromatin interactions
ENSG00000213926	chromatin interactions
ENSG00000272395	chromatin interactions
ENSG00000130755	chromatin interactions

Extended variants
information (count: 417 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:417 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs373809770	chr19:39727586-39727587	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
2	rs377479120	chr19:39727587-39727588	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
3	rs550876196	chr19:39727596-39727597	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
4	rs569200969	chr19:39727625-39727626	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
5	rs192512179	chr19:39727630-39727631	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
6	rs559006897	chr19:39727634-39727635	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
7	rs113982351	chr19:39727648-39727649	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
8	rs140237083	chr19:39727659-39727660	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
9	rs11673485	chr19:39727668-39727669	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs113413524	chr19:39727680-39727681	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
11	rs574920704	chr19:39727686-39727687	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
12	rs542437363	chr19:39727722-39727723	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
13	rs111485497	chr19:39727723-39727724	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
14	rs557205586	chr19:39727727-39727728	Enhancers Weak transcription	Chromatin interactive region	2 gene(s)	Overlapped CNVs	n/a
15	rs575549854	chr19:39727743-39727744	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
16	rs371033773	chr19:39727771-39727772	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
17	rs375510488	chr19:39727785-39727786	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
18	rs386809175	chr19:39727814-39727815	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
19	rs147576659	chr19:39727815-39727816	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
20	rs141762326	chr19:39727822-39727823	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
21	rs147080652	chr19:39727826-39727827	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
22	rs187511475	chr19:39727891-39727892	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
23	rs529055014	chr19:39727894-39727895	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
24	rs368369068	chr19:39727899-39727900	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
25	rs138569775	chr19:39727926-39727927	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
26	rs201769258	chr19:39727929-39727930	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
27	rs149214098	chr19:39727943-39727944	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
28	rs552557247	chr19:39727988-39727989	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
29	rs538983317	chr19:39727997-39727998	Enhancers Weak transcription	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
30	rs543023350	chr19:39728003-39728004	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
31	rs73553775	chr19:39728036-39728037	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
32	rs192649723	chr19:39728046-39728047	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
33	rs553170678	chr19:39728048-39728049	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
34	rs568564008	chr19:39728049-39728050	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
35	rs535619923	chr19:39728064-39728065	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
36	rs561559204	chr19:39728077-39728078	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
37	rs143258869	chr19:39728078-39728079	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
38	rs148297424	chr19:39728079-39728080	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	Chromatin interactive region	3 gene(s)	Overlapped CNVs	n/a
39	rs367756632	chr19:39728110-39728111	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
40	rs558073016	chr19:39728138-39728139	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
41	rs184992748	chr19:39728176-39728177	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
42	rs540248624	chr19:39728178-39728179	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
43	rs561403088	chr19:39728209-39728210	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
44	rs561598126	chr19:39728245-39728246	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
45	rs573851182	chr19:39728266-39728267	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
46	rs528997581	chr19:39728273-39728274	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
47	rs541228945	chr19:39728297-39728298	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
48	rs189660819	chr19:39728335-39728336	Flanking Active TSS Enhancers Bivalent Enhancer Flanking Bivalent TSS/Enh Bivalent/Poised TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
49	rs141388596	chr19:39728497-39728498	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a
50	rs559556973	chr19:39728507-39728508	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS	TF binding region Chromatin interactive region	4 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
Thoracic aortic aneurysm	21092924	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Autism	22495311	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Ductal carcinoma	22052326	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	21858162	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Disorders of sex development	21048976	CNVD
Ovarian cancer	22174824	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Breast cancer	21364760	CNVD
Invasive pancreatic ductal carcinoma	18765526	CNVD
Rhabdomyosarcoma	16790082	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
small cell lung cancer	20016488	CNVD
Wilms tumour	21544195	CNVD
Mental retardation	19951919	CNVD
19q13.11 deletion syndrome	22378287	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	21045282	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Ovarian neoplasms	16753589	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Lung cancer	21569311	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Breast cancer	21509527	CNVD
Gastric cancer	18160780	CNVD
Hepatocellular carcinoma	16750200	CNVD
Basal cell lymphoma	19029149	CNVD
Breast cancer	20409316	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Multiple myeloma	16616336	CNVD
Renal cell carcinoma	18765545	CNVD
Acute myeloid leukemia	20729466	CNVD
Lung cancer	18438408	CNVD

Chromatin state (count:111 , 50 per page) page: 1 2 3

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:39721400-39728200	Weak transcription	Stomach Mucosa	stomach
2	chr19:39725600-39728200	Weak transcription	Primary T cells from cord blood	blood
3	chr19:39726600-39729400	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
4	chr19:39726800-39728200	Enhancers	Primary T helper naive cells from peripheral blood	blood
5	chr19:39726800-39729200	Enhancers	Primary T killer naive cells fromperipheralblood	blood
6	chr19:39727000-39728200	Enhancers	Primary T cells fromperipheralblood	blood
7	chr19:39727000-39728200	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
8	chr19:39727000-39728400	Enhancers	Primary T helper cells fromperipheralblood	blood
9	chr19:39727200-39728200	Enhancers	Primary T helper cells PMA-I stimulated	--
10	chr19:39727200-39728200	Enhancers	Pancreas	Pancrea
11	chr19:39727200-39729000	Enhancers	Primary T helper memory cells from peripheral blood 1	blood
12	chr19:39727200-39729200	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
13	chr19:39727200-39729800	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
14	chr19:39727400-39728000	Enhancers	Primary T helper naive cells fromperipheralblood	blood
15	chr19:39727400-39728200	Enhancers	Primary T killer memory cells from peripheral blood	blood
16	chr19:39727400-39728400	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
17	chr19:39727400-39728400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
18	chr19:39727800-39728000	Enhancers	GM12878-XiMat	blood
19	chr19:39728000-39728200	Bivalent Enhancer	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
20	chr19:39728000-39728200	Enhancers	Primary hematopoietic stem cells short term culture	blood
21	chr19:39728000-39728400	Enhancers	Primary T cells effector/memory enriched fromperipheralblood	blood
22	chr19:39728000-39728400	Enhancers	Gastric	stomach
23	chr19:39728000-39728600	Flanking Active TSS	GM12878-XiMat	blood
24	chr19:39728000-39728800	Enhancers	Spleen	Spleen
25	chr19:39728000-39729000	Enhancers	Primary hematopoietic stem cells	blood
26	chr19:39728000-39729000	Flanking Active TSS	Primary T helper naive cells fromperipheralblood	blood
27	chr19:39728000-39729200	Enhancers	Primary B cells from peripheral blood	blood
28	chr19:39728000-39729200	Enhancers	Placenta	Placenta
29	chr19:39728200-39728400	Flanking Active TSS	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
30	chr19:39728200-39728400	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
31	chr19:39728200-39728400	Flanking Bivalent TSS/Enh	Foreskin Keratinocyte Primary Cells skin02	Skin
32	chr19:39728200-39728400	Flanking Active TSS	Duodenum Mucosa	Duodenum
33	chr19:39728200-39728400	Flanking Active TSS	Pancreas	Pancrea
34	chr19:39728200-39728400	Bivalent/Poised TSS	Rectal Mucosa Donor 29	rectum
35	chr19:39728200-39728400	Flanking Active TSS	Hela-S3	cervix
36	chr19:39728200-39728400	Enhancers	K562	blood
37	chr19:39728200-39728600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
38	chr19:39728200-39728600	Flanking Active TSS	Primary T killer memory cells from peripheral blood	blood
39	chr19:39728200-39728600	Bivalent Enhancer	Foreskin Keratinocyte Primary Cells skin03	Skin
40	chr19:39728200-39728800	Enhancers	Primary T cells from cord blood	blood
41	chr19:39728200-39728800	Flanking Active TSS	Primary T cells fromperipheralblood	blood
42	chr19:39728200-39728800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin01	Skin
43	chr19:39728200-39728800	Bivalent Enhancer	Foreskin Fibroblast Primary Cells skin02	Skin
44	chr19:39728200-39728800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
45	chr19:39728200-39728800	Enhancers	Liver	Liver
46	chr19:39728200-39728800	Enhancers	Esophagus	oesophagus
47	chr19:39728200-39728800	Active TSS	A549	lung
48	chr19:39728200-39729000	Flanking Active TSS	Primary T helper naive cells from peripheral blood	blood
49	chr19:39728200-39729000	Flanking Active TSS	Primary T helper cells PMA-I stimulated	--
50	chr19:39728200-39729000	Flanking Active TSS	Primary T regulatory cells fromperipheralblood	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links